BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19705261)

  • 1. HCV infection and cryptogenic cirrhosis are risk factors for hepatocellular carcinoma among Latinos in New York City.
    Guerrero-Preston R; Siegel A; Renz J; Vlahov D; Neugut A
    J Community Health; 2009 Dec; 34(6):500-5. PubMed ID: 19705261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular Carcinoma and Associated Clinical Features in Latino and Caucasian Patients from a Single Center.
    Kuftinec GN; Levy R; Kieffer DA; Medici V
    Ann Hepatol; 2019; 18(1):177-186. PubMed ID: 31113588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.
    Lee MH; Hsiao TI; Subramaniam SR; Le AK; Vu VD; Trinh HN; Zhang J; Jin M; Wong VW; Wong GL; Nguyen MH
    Am J Gastroenterol; 2017 Jul; 112(7):1111-1119. PubMed ID: 28440303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.
    El-Serag HB; Kramer J; Duan Z; Kanwal F
    Am J Gastroenterol; 2014 Sep; 109(9):1427-35. PubMed ID: 25070058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C-positive Black patients develop hepatocellular carcinoma at earlier stages of liver disease and present with a more aggressive phenotype.
    Shaltiel T; Zheng S; Siderides C; Gleeson EM; Carr J; Pletcher ER; Cohen NA; Golas BJ; Magge DR; Labow DM; Branch AD; Sarpel U
    Cancer; 2021 May; 127(9):1395-1406. PubMed ID: 33629759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors for hepatocellular carcinoma in Texas Latinos: implications for prevention research.
    Ramirez AG; Weiss NS; Holden AE; Suarez L; Cooper SP; Munoz E; Naylor SL
    PLoS One; 2012; 7(4):e35573. PubMed ID: 22530052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Race and Ethnicity with Hepatocellular Carcinoma, Decompensation, and Mortality in US Veterans with Cirrhosis.
    VoPham T; Cravero A; Feld LD; Green P; Feng Z; Berry K; Kim NJ; Vutien P; Mendoza JA; Ioannou GN
    Cancer Epidemiol Biomarkers Prev; 2023 Aug; 32(8):1069-1078. PubMed ID: 37255388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.
    Jun TW; Yeh ML; Yang JD; Chen VL; Nguyen P; Giama NH; Huang CF; Hsing AW; Dai CY; Huang JF; Chuang WL; Roberts LR; Yu ML; Nguyen MH
    Liver Int; 2018 May; 38(5):895-902. PubMed ID: 29045023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of hepatocellular carcinoma in Texas Latinos, 1995-2010: an update.
    Ramirez AG; Munoz E; Holden AE; Adeigbe RT; Suarez L
    PLoS One; 2014; 9(6):e99365. PubMed ID: 24915432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic Cohort.
    Setiawan VW; Wei PC; Hernandez BY; Lu SC; Monroe KR; Le Marchand L; Yuan JM
    Cancer; 2016 May; 122(9):1444-52. PubMed ID: 26916271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for primary hepatocellular carcinoma in black and white Americans in 2000.
    Yu L; Sloane DA; Guo C; Howell CD
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):355-60. PubMed ID: 16527700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent trends of Japanese hepatocellular carcinoma due to HCV in aging society.
    Hiraoka A; Hidaka S; Shimizu Y; Utsunomiya H; Imai Y; Tatsukawa H; Tazuya N; Yamago H; Yorimitsu N; Tanihira T; Hasebe A; Miyamoto Y; Ninomiya T; Kawasaki H; Hirooka M; Abe M; Hiasa Y; Matsuura B; Onji M; Michitaka K
    Hepatogastroenterology; 2012 Sep; 59(118):1893-5. PubMed ID: 22193439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after curative treatment for cryptogenic cirrhosis-associated hepatocellular carcinoma satisfying the Milan criteria.
    Takuma Y; Nouso K; Makino Y; Gotoh T; Toshikuni N; Morimoto Y; Shimomura H; Yamamoto H
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1417-24. PubMed ID: 21884248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse relationship between cirrhosis and massive tumours in hepatocellular carcinoma.
    Sarpel U; Ayo D; Lobach I; Xu R; Newman E
    HPB (Oxford); 2012 Nov; 14(11):741-5. PubMed ID: 23043662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study.
    Benvegnù L; Fattovich G; Noventa F; Tremolada F; Chemello L; Cecchetto A; Alberti A
    Cancer; 1994 Nov; 74(9):2442-8. PubMed ID: 7922998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma incidence post direct-acting antivirals in hepatitis C-related advanced fibrosis/cirrhosis patients in Australia.
    Chan PPY; Levy MT; Shackel N; Davison SA; Prakoso E
    Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):541-546. PubMed ID: 32660841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation and survival of Asian and non-Asian patients with HCV-related hepatocellular carcinoma.
    Yip B; Wantuck JM; Kim LH; Wong RJ; Ahmed A; Garcia G; Nguyen MH
    Dig Dis Sci; 2014 Jan; 59(1):192-200. PubMed ID: 24282055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
    Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
    Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.